Predicting the Stone-Free Status of Percutaneous Nephrolithotomy with the Machine Learning System.

IF 2.1 Q2 UROLOGY & NEPHROLOGY
Rami AlAzab, Owais Ghammaz, Nabil Ardah, Ayah Al-Bzour, Layan Zeidat, Zahraa Mawali, Yaman B Ahmed, Tha'er Abdulkareem Alguzo, Azhar Mohanad Al-Alwani, Mahmoud Samara
{"title":"Predicting the Stone-Free Status of Percutaneous Nephrolithotomy with the Machine Learning System.","authors":"Rami AlAzab,&nbsp;Owais Ghammaz,&nbsp;Nabil Ardah,&nbsp;Ayah Al-Bzour,&nbsp;Layan Zeidat,&nbsp;Zahraa Mawali,&nbsp;Yaman B Ahmed,&nbsp;Tha'er Abdulkareem Alguzo,&nbsp;Azhar Mohanad Al-Alwani,&nbsp;Mahmoud Samara","doi":"10.2147/IJNRD.S427404","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The study aimed to create a machine learning model (MLM) to predict the stone-free status (SFS) of patients undergoing percutaneous nephrolithotomy (PCNL) and compare its performance to the S.T.O.N.E. and Guy's stone scores.</p><p><strong>Patients and methods: </strong>This is a retrospective study that included 320 PCNL patients. Pre-operative and post-operative variables were extracted and entered into three MLMs: RFC, SVM, and XGBoost. The methods used to assess the performance of each were mean bootstrap estimate, 10-fold cross-validation, classification report, and AUC. Each model was externally validated and evaluated by mean bootstrap estimate with CI, classification report, and AUC.</p><p><strong>Results: </strong>Out of the 320 patients who underwent PCNL, the SFS was found to be 69.4%. The RFC mean bootstrap estimate was 0.75 and 95% CI: [0.65-0.85], 10-fold cross-validation of 0.744, an accuracy of 0.74, and AUC of 0.761. The XGBoost results were 0.74 [0.63-0.85], 0.759, 0.72, and 0.769, respectively. The SVM results were 0.70 [0.60-0.79], 0.725, 0.74, and 0.751, respectively. The AUC of Guy's stone score and the S.T.O.N.E. score were 0.666 and 0.71, respectively. The RFC external validation set had a mean bootstrap estimate of 0.87 and 95% CI: [0.81-0.92], an accuracy of 0.70, and an AUC of 0.795, While the XGBoost results were 0.84 [0.78-0.91], 0.74, and 0.84, respectively. The SVM results were 0.86 [0.80-0.91], 0.79, and 0.858, respectively.</p><p><strong>Conclusion: </strong>MLMs can be used with high accuracy in predicting SFS for patients undergoing PCNL. MLMs we utilized predicted the SFS with AUCs superior to those of GSS and S.T.O.N.E scores.</p>","PeriodicalId":14181,"journal":{"name":"International Journal of Nephrology and Renovascular Disease","volume":"16 ","pages":"197-206"},"PeriodicalIF":2.1000,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a8/ae/ijnrd-16-197.PMC10503523.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nephrology and Renovascular Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/IJNRD.S427404","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The study aimed to create a machine learning model (MLM) to predict the stone-free status (SFS) of patients undergoing percutaneous nephrolithotomy (PCNL) and compare its performance to the S.T.O.N.E. and Guy's stone scores.

Patients and methods: This is a retrospective study that included 320 PCNL patients. Pre-operative and post-operative variables were extracted and entered into three MLMs: RFC, SVM, and XGBoost. The methods used to assess the performance of each were mean bootstrap estimate, 10-fold cross-validation, classification report, and AUC. Each model was externally validated and evaluated by mean bootstrap estimate with CI, classification report, and AUC.

Results: Out of the 320 patients who underwent PCNL, the SFS was found to be 69.4%. The RFC mean bootstrap estimate was 0.75 and 95% CI: [0.65-0.85], 10-fold cross-validation of 0.744, an accuracy of 0.74, and AUC of 0.761. The XGBoost results were 0.74 [0.63-0.85], 0.759, 0.72, and 0.769, respectively. The SVM results were 0.70 [0.60-0.79], 0.725, 0.74, and 0.751, respectively. The AUC of Guy's stone score and the S.T.O.N.E. score were 0.666 and 0.71, respectively. The RFC external validation set had a mean bootstrap estimate of 0.87 and 95% CI: [0.81-0.92], an accuracy of 0.70, and an AUC of 0.795, While the XGBoost results were 0.84 [0.78-0.91], 0.74, and 0.84, respectively. The SVM results were 0.86 [0.80-0.91], 0.79, and 0.858, respectively.

Conclusion: MLMs can be used with high accuracy in predicting SFS for patients undergoing PCNL. MLMs we utilized predicted the SFS with AUCs superior to those of GSS and S.T.O.N.E scores.

Abstract Image

Abstract Image

Abstract Image

用机器学习系统预测经皮肾穿刺取石术无结石状态。
目的:本研究旨在创建一个机器学习模型(MLM)来预测经皮肾取石术(PCNL)患者的无结石状态(SFS),并将其性能与S.T.O.N.E.和Guy’S结石评分进行比较。患者和方法:这是一项回顾性研究,包括320名PCNL患者。提取术前和术后变量,并将其输入三个MLM:RFC、SVM和XGBoost。用于评估每种方法性能的方法是平均自举估计、10倍交叉验证、分类报告和AUC。每个模型都经过了外部验证,并通过平均bootstrap估计与CI、分类报告和AUC进行了评估。结果:在320名接受PCNL的患者中,SFS为69.4%。RFC平均Bootstramp估计为0.75,95%CI:[0.65-0.85],10倍交叉验证为0.744,准确度为0.74,AUC为0.761。XGBoost结果分别为0.74[0.63-0.85]、0.759、0.72和0.769。SVM结果分别为0.70[0.60-0.79]、0.725、0.74和0.751。Guy’s stone评分的AUC和s.T.O.N.E.评分分别为0.666和0.71。RFC外部验证集的平均bootstrap估计值为0.87,95%CI:[0.81-0.92],准确度为0.70,AUC为0.795,而XGBoost结果分别为0.84[0.78-0.91],0.74和0.84。SVM结果分别为0.86[0.80-0.91]、0.79和0.858。结论:MLM可用于预测PCNL患者的SFS,具有较高的准确性。我们使用的MLM预测SFS的AUC优于GSS和S.T.O.N.E评分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.90
自引率
5.00%
发文量
40
审稿时长
16 weeks
期刊介绍: International Journal of Nephrology and Renovascular Disease is an international, peer-reviewed, open-access journal focusing on the pathophysiology of the kidney and vascular supply. Epidemiology, screening, diagnosis, and treatment interventions are covered as well as basic science, biochemical and immunological studies. In particular, emphasis will be given to: -Chronic kidney disease- Complications of renovascular disease- Imaging techniques- Renal hypertension- Renal cancer- Treatment including pharmacological and transplantation- Dialysis and treatment of complications of dialysis and renal disease- Quality of Life- Patient satisfaction and preference- Health economic evaluations. The journal welcomes submitted papers covering original research, basic science, clinical studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports and extended reports. The main focus of the journal will be to publish research and clinical results in humans but preclinical, animal and in vitro studies will be published where they shed light on disease processes and potential new therapies and interventions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信